Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
- PMID: 15541308
- DOI: 10.1016/j.neuron.2004.10.023
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
Abstract
Parkinson's disease (PD; OMIM #168600) is the second most common neurodegenerative disorder in the Western world and presents as a progressive movement disorder. The hallmark pathological features of PD are loss of dopaminergic neurons from the substantia nigra and neuronal intracellular Lewy body inclusions. Parkinsonism is typically sporadic in nature; however, several rare familial forms are linked to genetic loci, and the identification of causal mutations has provided insight into the disease process. PARK8, identified in 2002 by Funayama and colleagues, appears to be a common cause of familial PD. We describe here the cloning of a novel gene that contains missense mutations segregating with PARK8-linked PD in five families from England and Spain. Because of the tremor observed in PD and because a number of the families are of Basque descent, we have named this protein dardarin, derived from the Basque word dardara, meaning tremor.
Comment in
-
Protein kinases linked to the pathogenesis of Parkinson's disease.Neuron. 2004 Nov 18;44(4):575-7. doi: 10.1016/j.neuron.2004.11.008. Neuron. 2004. PMID: 15541303
Similar articles
-
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.Brain. 2005 Dec;128(Pt 12):2786-96. doi: 10.1093/brain/awh667. Epub 2005 Nov 4. Brain. 2005. PMID: 16272164
-
Familial Parkinson's disease: clinical and genetic analysis of four Basque families.Ann Neurol. 2005 Mar;57(3):365-72. doi: 10.1002/ana.20391. Ann Neurol. 2005. PMID: 15732106
-
Generation of a human iPSC line (CIBi014-A) from a patient with Parkinson's disease carrying a novel heterozygotic PARK8 (LRRK2) mutation.Stem Cell Res. 2023 Feb;66:102995. doi: 10.1016/j.scr.2022.102995. Epub 2022 Dec 9. Stem Cell Res. 2023. PMID: 36528012
-
[Clinical molecular genetics for PARK8 (LRRK2)].Brain Nerve. 2007 Aug;59(8):839-50. Brain Nerve. 2007. PMID: 17713120 Review. Japanese.
-
α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.Neurotoxicology. 2011 Oct;32(5):622-9. doi: 10.1016/j.neuro.2011.01.003. Epub 2011 Jan 14. Neurotoxicology. 2011. PMID: 21238487 Free PMC article. Review.
Cited by
-
Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.Parkinsonism Relat Disord. 2013 Jun;19(6):595-9. doi: 10.1016/j.parkreldis.2013.02.008. Epub 2013 Mar 16. Parkinsonism Relat Disord. 2013. PMID: 23507417 Free PMC article.
-
Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R¹⁴⁴¹G) transgenic mouse.Neurosci Lett. 2013 Aug 9;549:57-62. doi: 10.1016/j.neulet.2013.05.034. Epub 2013 May 28. Neurosci Lett. 2013. PMID: 23721786 Free PMC article.
-
The roles of redox enzymes in Parkinson's disease: Focus on glutaredoxin.Ther Targets Neurol Dis. 2015;2(2):e790. Ther Targets Neurol Dis. 2015. PMID: 26097894 Free PMC article.
-
Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers.PLoS One. 2012;7(8):e43472. doi: 10.1371/journal.pone.0043472. Epub 2012 Aug 29. PLoS One. 2012. PMID: 22952686 Free PMC article.
-
Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases.Neurobiol Dis. 2013 Oct;58:183-90. doi: 10.1016/j.nbd.2013.05.017. Epub 2013 Jun 5. Neurobiol Dis. 2013. PMID: 23747310 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases